Prometheus Laboratories Inc. announced the launch of MyCeliacID. The MyCeliacID identifies distinct genetic sequences associated with celiac disease, a largely undiagnosed genetic disorder that affects approximately 3 million people in the US. It is the saliva-based version of a blood test used by doctors.
“Prometheus is a leader in celiac genetic testing, performing more than 80,000 blood-based genetic tests for celiac disease to date,” said Ron Rocca, Prometheus’ General Manager, Gastrointestinal Products. “An estimated 1% of people in the US live with celiac disease however many remain undiagnosed. We have decided to make MyCeliacID, a highly-reliable, non-invasive, DNA-based test for celiac disease, available directly to the public so that people who are searching for answers can have better information about their condition.”
Celiac disease appears in individuals genetically predisposed to the disease and who consume gluten, a protein found in grains such as wheat, barley and rye. MyCeliacID is the only test that provides individuals with their risk of developing the disease relative to the general population. In addition, MyCeliacID can virtually rule out celiac disease in a person’s lifetime. A negative test result indicates that the individual does not have the genes associated with celiac disease and is highly unlikely to develop the disease. A positive result indicates that the individual has one or more genes that predispose to celiac disease, however it is not an indication of the disease itself. Individuals with a positive test result should see a physician, who may elect to perform other testing. Only a doctor can diagnose celiac disease.
“When my son Tyler was diagnosed in 1991, genetic testing for celiac disease wasn’t available,” said Danna Korn, founder of Raising Our Celiac Kids (ROCK). “It took two frustrating years of searching for answers and for the cause of my son’s symptoms. With MyCeliacID, you can quickly find out if you or a loved one has the genes for celiac disease.”